ImpediMed Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, ImpediMed stock has a consensus rating of "Strong Buy" and an average price target of $0.03. The average 1-year stock price forecast is 328.57% higher than the current stock price, while the lowest is $0.02 (+185.71%) and the highest is $0.06 (+757.14%).

Price Target: $0.03 (+328.57%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$0.02	$0.03	$0.02	$0.06
Change	+185.71%	+328.57%	+185.71%	+757.14%

Analyst Ratings

The average analyst rating for ImpediMed stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	May '26
Strong Buy	3	4	4	4	4	4
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	4	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Tom Godfrey Ord Minnett	Ord Minnett	Buy Maintains $0.05 → $0.02	Buy	Maintains	$0.05 → $0.02	+185.71%	May 12, 2026
Martyn Jacobs Bell Potter	Bell Potter	Buy Maintains $0.01	Buy	Maintains	$0.01	+42.86%	May 11, 2026
Scott Power Morgans	Morgans	Buy Maintains $0.05 → $0.02	Buy	Maintains	$0.05 → $0.02	+185.71%	May 5, 2026
Shane Storey Canaccord Genuity	Canaccord Genuity	Buy Maintains $0.07 → $0.06	Buy	Maintains	$0.07 → $0.06	+757.14%	Feb 2, 2026

Financial Forecast

Revenue This Year

14.78M

from 12.72M

16.16%

from 12.72M

Revenue Next Year

20.24M

from 14.78M

36.92%

from 14.78M

EPS This Year

-0.01

from -0.01

EPS Next Year

-0.00

from -0.01

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Jun 30, 2021	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026
Revenue	8.41M	10.57M	11.34M	10.32M	12.72M	14.78M
Revenue Growth	46.47%	25.65%	7.36%	-9.04%	23.31%	16.16%
Gross Profit	6.86M	8.86M	9.80M	9.01M	10.98M	12.71M
Gross Margin	81.54%	83.83%	86.37%	87.27%	86.25%	86.00%
Operating Income	-22.97M	-21.47M	-22.87M	-23.07M	-23.01M	-19.69M
Net Income	-20.71M	-19.87M	-20.52M	-19.79M	-23.24M	-21.61M
EPS	-	-	-	-	-0.01	-0.01
Free Cash Flow	-9.13M	-13.31M	-18.95M	-15.83M	-9.36M	-21.60M
No. Analysts	-	-	-	-	-	2

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.

Revenue Forecast

Revenue	2026	2027	2028
High	15.0M
Avg	14.8M
Low	14.6M

Revenue Growth

Revenue Growth	2026	2027	2028
High	17.6%
Avg	16.2%
Low	14.7%

EPS Forecast

EPS	2026	2027	2028
High	-0.01
Avg	-0.01
Low	-0.01

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-